Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Brii Biosciences Limited ( (HK:2137) ) has provided an announcement.
Brii Biosciences Limited has announced a board meeting scheduled for March 21, 2025, to consider and approve the annual results for the year ending December 31, 2024. This meeting is crucial for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the coming year.
More about Brii Biosciences Limited
Brii Biosciences Limited is a biotechnology company incorporated in the Cayman Islands, focusing on developing innovative therapies. It operates within the pharmaceutical industry, with a market focus on addressing significant health challenges through its subsidiaries.
YTD Price Performance: 100%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €183.9M
Learn more about 2137 stock on TipRanks’ Stock Analysis page.